Literature DB >> 30841438

Propranolol selectively inhibits cervical cancer cell growth by suppressing the cGMP/PKG pathway.

Liuyun Gong1, Yutiantian Lei1, Xinyue Tan1, Yiping Dong1, Zhenzhen Luo1, Dan Zhang2, Suxia Han3.   

Abstract

AIM: To observe the effect of propranolol in cervical cancer and investigate the mechanism of the effect. METHODS AND
RESULTS: We found 5 direct protein targets (DPTs) of propranolol (PRO) by DrugBank5.0 firstly. Next, we analyzed protein-protein interaction (PPI) network and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of PRO DPTs and the result showed that PRO was linked with cGMP/PKG pathway. Then, we recognized the top 38 upexpressed genes of cervical cancer (CC) based original microarray datasets (GSE7803, GSE9750, GSE39001 and GSE63514). Further, we analyzed the biological process with the 38 overexpressed genes by STRING. We found some of overexpressed genes of CC participated in GMP biosynthetic process. Lastly, the function of PRO in CC was validated by MTT assay, Western blotting, flow cytometry and colony formation assay methods. We verified PRO can suppress cGMP/PKG pathway then inhibits CC cell growth.
CONCLUSION: The bioinformatical analysis combine with traditional experiment can help us understanding potential molecular mechanism about how PRO acting in CC. This method is a new paradigm which can guide future researches about mechanism in existing diseases and drugs.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Apoptosis; Bioinformatical analysis; Cervical cancer; Proliferation; Propranolol; cGMP-PKG signaling pathway

Mesh:

Substances:

Year:  2019        PMID: 30841438     DOI: 10.1016/j.biopha.2019.01.027

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Bioinformatics Analysis Highlights Five Differentially Expressed Genes as Prognostic Biomarkers of Cervical Cancer and Novel Option for Anticancer Treatment.

Authors:  Hongtu Cui; Ruilin Ma; Tao Hu; Gary Guishan Xiao; Chengjun Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

2.  Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis.

Authors:  Dazhong Liu; Pengfei Zhang; Jiaying Zhao; Lei Yang; Wei Wang
Journal:  Biomed Res Int       Date:  2021-05-19       Impact factor: 3.411

Review 3.  Stress Hormones: Emerging Targets in Gynecological Cancers.

Authors:  Guoqiang Chen; Lei Qiu; Jinghai Gao; Jing Wang; Jianhong Dang; Lingling Li; Zhijun Jin; Xiaojun Liu
Journal:  Front Cell Dev Biol       Date:  2021-07-09

4.  Stromal score as a prognostic factor in primary gastric cancer and close association with tumor immune microenvironment.

Authors:  Min Mao; Qingliang Yu; Rongzhi Huang; Yunxin Lu; Zhen Wang; Liang Liao
Journal:  Cancer Med       Date:  2020-05-20       Impact factor: 4.452

5.  The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.

Authors:  Tian Xiang; Chunhui Yuan; Xia Guo; Honghao Wang; Qinzhen Cai; Yun Xiang; Wei Luo; Gao Liu
Journal:  Cell Death Dis       Date:  2021-02-04       Impact factor: 8.469

Review 6.  New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil.

Authors:  Marian Cruz-Burgos; Alberto Losada-Garcia; Carlos D Cruz-Hernández; Sergio A Cortés-Ramírez; Ignacio Camacho-Arroyo; Vanessa Gonzalez-Covarrubias; Miguel Morales-Pacheco; Samantha I Trujillo-Bornios; Mauricio Rodríguez-Dorantes
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

7.  Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma.

Authors:  Xiang-Ming Wang; Shang-Wei Chen; Gang Chen; Hua-Fu Zhou; Ting-Qing Gan; Jing-Jing Zeng; Zu-Yun Li
Journal:  Anal Cell Pathol (Amst)       Date:  2021-11-29       Impact factor: 2.916

Review 8.  Neural plasticity of the uterus: New targets for endometrial cancer?

Authors:  Pia Español; Rocio Luna; Cristina Soler; Pablo Caruana; Amanda Altés-Arranz; Francisco Rodríguez; Oriol Porta; Olga Sanchez; Elisa Llurba; Ramón Rovira; María Virtudes Céspedes
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.